United States Biotechnology & Medical Research

Oramed Pharmaceuticals Inc (ORMP)

Oramed Pharmaceuticals experienced four insider trading transactions recently, all involving planned or proposed sales by executives Joshua Hexter and Avi Gabay. These divestments occurred following an earnings report that missed expectations. The stock price has declined 6.4% over the past ninety days, reflecting ongoing market pressure for the healthcare firm.
Ticker: ORMP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oramed Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Hexter Joshua COO & CBO Officer
Transaction date
Planned sale
Price
438.05
Quantity 8,355 -11.6%
Value US$3,192,652
Gabay Avraham Chief Financial Officer Officer
Transaction date
Planned sale
Price
433.23
Quantity 8,976 -4.9%
Value US$4,745,827
Avi Gabay Officer Officer
Transaction date
Proposed sale
Price
496.57
Quantity 83,787
Value US$3,370,694
Joshua Hexter Officer Officer
Transaction date
Proposed sale
Price
4.67
Quantity 30,000
Value US$140,100
Gabay Avraham Chief Financial Officer Officer
Transaction date
Planned sale
Price
4.51
Quantity 73,360 -9.8%
Value US$330,744
Hexter Joshua COO & CBO Officer
Transaction date
Planned sale
Price
4.46
Quantity 137,000 -11.8%
Value US$611,431
Hexter Joshua Officer Officer
Transaction date
Proposed sale
Price
4.81
Quantity 137,000
Value US$658,970
Gabay Avraham Officer Officer
Transaction date
Proposed sale
Price
4.81
Quantity 93,360
Value US$449,062
4.0
Mayer Arie Non-Executive Director
Transaction date
Purchase
Price
2.21
Quantity 3,800 +16.5%
Value US$8,398
4.0
Mayer Arie Non-Executive Director
Transaction date
Purchase
Price
2.22
Quantity 5,009 +27.8%
Value US$11,120
3.6
KIDRON NADAV President and CEO Executive Director
Transaction date
Purchase
Price
2.04
Quantity 26,000 +26.0%
Value US$53,014
0.5
Kidron Miriam Chief Scientific Officer Executive Director
Transaction date
Sale
Price
2.01
Quantity 100,000 -33.1%
Value US$201,000
3.6
KIDRON NADAV President and CEO Executive Director
Transaction date
Purchase
Price
2.01
Quantity 100,000 New position
Value US$201,000
4.0
Rozov Yadin Non-Executive Director
Transaction date
Purchase
Price
2.05
Quantity 50,000 +137.0%
Value US$102,450
4.0
Rozov Yadin Non-Executive Director
Transaction date
Purchase
Price
1.96
Quantity 20,000 +121.2%
Value US$39,120
Rabinowitz Michael Chief Commercial Officer Officer
Transaction date
Planned sale
Price
12.49
Quantity 11,900 -8.6%
Value US$148,651
Rabinowitz Michael Chief Commercial Officer Officer
Transaction date
Planned sale
Price
13.01
Quantity 1,425 -1.0%
Value US$18,544
2.9
RAKIN KEVIN Non-Executive Director
Transaction date
Sale
Price
9.41
Quantity 10,000 -17.6%
Value US$94,096
4.0
Mayer Arie Non-Executive Director
Transaction date
Sale
Price
25.60
Quantity 3,000 -100.0%
Value US$76,800
3.6
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
20.11
Quantity 220,000 -25.3%
Value US$4,423,144
2.2
Sank Leonard
Transaction date
Purchase
Price
2.95
Quantity 10,000 +2.7%
Value US$29,500
2.2
Sank Leonard
Transaction date
Purchase
Price
2.90
Quantity 15,000 +4.3%
Value US$43,500
2.2
Sank Leonard
Transaction date
Purchase
Price
3.86
Quantity 4,497 +1.3%
Value US$17,336
2.2
Sank Leonard
Transaction date
Purchase
Price
3.74
Quantity 10,020 +3.0%
Value US$37,497
2.2
Sank Leonard
Transaction date
Purchase
Price
3.58
Quantity 20,000 +6.3%
Value US$71,562
2.2
Sank Leonard
Transaction date
Purchase
Price
3.47
Quantity 20,000 +6.8%
Value US$69,316
2.2
Sank Leonard
Transaction date
Purchase
Price
3.22
Quantity 1,320 +0.4%
Value US$4,250
Friedman Aviad Non-Executive Director
Transaction date
Purchase
Price
4.98
Quantity 2,000 +19.6%
Value US$9,960
Friedman Aviad Non-Executive Director
Transaction date
Purchase
Price
4.82
Quantity 500 +5.2%
Value US$2,410
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
5.92
Quantity 122 +0.0%
Value US$722
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Sale
Price
5.98
Quantity 61 -0.0%
Value US$365
Kidron Miriam Chief Scientific Officer Executive Director
Transaction date
Sale
Price
8.50
Quantity 89,636 -54.4%
Value US$761,906
Li Xiaopeng
Transaction date
Purchase
Price
8.50
Quantity 89,636 +76.8%
Value US$761,906
Li Xiaopeng
Transaction date
Purchase
Price
6.33
Quantity 52,814 +82.7%
Value US$334,313
Kidron Miriam Chief Scientific Officer Executive Director
Transaction date
Sale
Price
6.33
Quantity 52,814 -37.1%
Value US$334,313
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
7.10
Quantity 100 +0.0%
Value US$710
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 300 +0.0%
Value US$2,100
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.91
Quantity 300 +0.0%
Value US$2,073
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.90
Quantity 300 +0.0%
Value US$2,070
JACOB HAROLD Non-Executive Director
Transaction date
Sale
Price
6.45
Quantity 8,500 -34.1%
Value US$54,842
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
8.61
Quantity 24,000 -14.4%
Value US$206,707
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
9.08
Quantity 15,000 -8.3%
Value US$136,178
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
9.27
Quantity 11,000 -5.7%
Value US$101,915
Berelowitz Michael Non-Executive Director
Transaction date
Sale
Price
9.44
Quantity 700 -3.0%
Value US$6,608
Berelowitz Michael Non-Executive Director
Transaction date
Sale
Price
8.70
Quantity 761 -3.1%
Value US$6,621
Berelowitz Michael Non-Executive Director
Transaction date
Sale
Price
8.70
Quantity 539 -2.2%
Value US$4,689
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.64
Quantity 100 +0.0%
Value US$664
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.63
Quantity 200 +0.0%
Value US$1,326
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.62
Quantity 100 +0.0%
Value US$662
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
6.55
Quantity 200 +0.0%
Value US$1,310
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 100 +0.0%
Value US$400
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.92
Quantity 1,100 +0.1%
Value US$4,312
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.95
Quantity 400 +0.0%
Value US$1,580
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.80
Quantity 500 +0.1%
Value US$1,900
KIDRON NADAV President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.78
Quantity 500 +0.1%
Value US$1,890
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
8.44
Quantity 8,699 -7.8%
Value US$73,401
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
8.40
Quantity 23,000 -17.1%
Value US$193,260
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
9.41
Quantity 8,301 -5.8%
Value US$78,112
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
4.44
Quantity 2,252 +0.2%
Value US$9,999
JACOB HAROLD Non-Executive Director
Transaction date
Purchase
Price
14.41
Quantity 700 New position
Value US$10,087
Kidron Miriam Chief Technology Officer Executive Director
Transaction date
Sale
Price
12.03
Quantity 137,300 -100.0%
Value US$1,651,582
Berelowitz Michael Non-Executive Director
Transaction date
Sale
Price
10.50
Quantity 9,434 -100.0%
Value US$99,057
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
10.90
Quantity 47,300 +3.4%
Value US$515,551
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
10.15
Quantity 27,700 +2.0%
Value US$281,257
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
14.96
Quantity 26,800 +2.0%
Value US$400,941
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
16.32
Quantity 24,492 +1.8%
Value US$399,798
JACOB HAROLD Non-Executive Director
Transaction date
Sale
Price
15.00
Quantity 834 -100.0%
Value US$12,510
REGALS CAPITAL MANAGEMENT LP Large shareholder
Transaction date
Purchase
Price
7.40
Quantity 6,630 +0.5%
Value US$49,034
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.32
Quantity 937,500 New position
Value US$300,000
Bronfeld Zeev Large shareholder
Transaction date
Sale
Price
0.28
Quantity 350,000 -5.7%
Value US$98,000
Bronfeld Zeev Large shareholder
Transaction date
Purchase
Price
0.32
Quantity 781,250 +12.1%
Value US$250,000
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.25
Quantity 5,000 +0.1%
Value US$1,250
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.25
Quantity 15,650 +0.4%
Value US$3,912
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 22,840 +0.6%
Value US$6,852
Sank Leonard Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 48,000 +1.4%
Value US$14,400
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-10-01 PlS Planned sale
Hexter Joshua

COO & CBO

Officer
8,355 -11.6%
438.05
US$3,192,652 		8,355 -11.6% 438.05 US$3,192,652
2026-10-02 2026-10-01 PlS Planned sale
Gabay Avraham

Chief Financial Officer

Officer
8,976 -4.9%
433.23
US$4,745,827 		8,976 -4.9% 433.23 US$4,745,827
2026-10-01 2026-10-01 PrS Proposed sale
Avi Gabay

Officer

Officer
83,787
496.57
US$3,370,694 		83,787 496.57 US$3,370,694
2026-10-01 2026-10-01 PrS Proposed sale
Joshua Hexter

Officer

Officer
30,000
4.67
US$140,100 		30,000 4.67 US$140,100
2026-07-02 2026-07-01 PlS Planned sale
Gabay Avraham

Chief Financial Officer

Officer
73,360 -9.8%
4.51
US$330,744 		73,360 -9.8% 4.51 US$330,744
2026-07-02 2026-07-01 PlS Planned sale
Hexter Joshua

COO & CBO

Officer
137,000 -11.8%
4.46
US$611,431 		137,000 -11.8% 4.46 US$611,431
2026-07-01 2026-07-01 PrS Proposed sale
Hexter Joshua

Officer

Officer
137,000
4.81
US$658,970 		137,000 4.81 US$658,970
2026-07-01 2026-07-01 PrS Proposed sale
Gabay Avraham

Officer

Officer
93,360
4.81
US$449,062 		93,360 4.81 US$449,062
2023-04-04 2023-04-04 B Purchase
4.0
Mayer Arie
Non-Executive Director
3,800 +16.5%
2.21
US$8,398 		3,800 +16.5% 2.21 US$8,398
2023-04-04 2023-04-03 B Purchase
4.0
Mayer Arie
Non-Executive Director
5,009 +27.8%
2.22
US$11,120 		5,009 +27.8% 2.22 US$11,120
2023-03-16 2023-03-16 B Purchase
3.6
KIDRON NADAV

President and CEO

Executive Director
26,000 +26.0%
2.04
US$53,014 		26,000 +26.0% 2.04 US$53,014
2023-03-15 2023-03-14 S Sale
0.5
Kidron Miriam

Chief Scientific Officer

Executive Director
100,000 -33.1%
2.01
US$201,000 		100,000 -33.1% 2.01 US$201,000
2023-03-15 2023-03-14 B Purchase
3.6
KIDRON NADAV

President and CEO

Executive Director
100,000 New position
2.01
US$201,000 		100,000 New position 2.01 US$201,000
2023-03-15 2023-03-14 B Purchase
4.0
Rozov Yadin
Non-Executive Director
50,000 +137.0%
2.05
US$102,450 		50,000 +137.0% 2.05 US$102,450
2023-03-15 2023-03-13 B Purchase
4.0
Rozov Yadin
Non-Executive Director
20,000 +121.2%
1.96
US$39,120 		20,000 +121.2% 1.96 US$39,120
2023-01-04 2023-01-03 PlS Planned sale
Rabinowitz Michael

Chief Commercial Officer

Officer
11,900 -8.6%
12.49
US$148,651 		11,900 -8.6% 12.49 US$148,651
2023-01-04 2023-01-03 PlS Planned sale
Rabinowitz Michael

Chief Commercial Officer

Officer
1,425 -1.0%
13.01
US$18,544 		1,425 -1.0% 13.01 US$18,544
2022-03-22 2022-03-21 S Sale
2.9
RAKIN KEVIN
Non-Executive Director
10,000 -17.6%
9.41
US$94,096 		10,000 -17.6% 9.41 US$94,096
2022-05-10 2021-11-01 S Sale
4.0
Mayer Arie
Non-Executive Director
3,000 -100.0%
25.60
US$76,800 		3,000 -100.0% 25.60 US$76,800
2021-08-11 2021-08-09 PlS Planned sale
3.6
KIDRON NADAV

President and CEO

Executive Director Large shareholder
220,000 -25.3%
20.11
US$4,423,144 		220,000 -25.3% 20.11 US$4,423,144
2019-09-11 2019-09-09 B Purchase
2.2
Sank Leonard
10,000 +2.7%
2.95
US$29,500 		10,000 +2.7% 2.95 US$29,500
2019-09-11 2019-09-09 B Purchase
2.2
Sank Leonard
15,000 +4.3%
2.90
US$43,500 		15,000 +4.3% 2.90 US$43,500
2019-07-18 2019-07-18 B Purchase
2.2
Sank Leonard
4,497 +1.3%
3.86
US$17,336 		4,497 +1.3% 3.86 US$17,336
2019-07-18 2019-07-17 B Purchase
2.2
Sank Leonard
10,020 +3.0%
3.74
US$37,497 		10,020 +3.0% 3.74 US$37,497
2019-07-18 2019-07-17 B Purchase
2.2
Sank Leonard
20,000 +6.3%
3.58
US$71,562 		20,000 +6.3% 3.58 US$71,562
2019-07-18 2019-07-16 B Purchase
2.2
Sank Leonard
20,000 +6.8%
3.47
US$69,316 		20,000 +6.8% 3.47 US$69,316
2019-07-15 2019-07-11 B Purchase
2.2
Sank Leonard
1,320 +0.4%
3.22
US$4,250 		1,320 +0.4% 3.22 US$4,250
2018-08-13 2018-08-09 B Purchase Friedman Aviad Non-Executive Director
2,000 +19.6%
4.98
US$9,960 		2,000 +19.6% 4.98 US$9,960
2018-08-13 2018-08-09 B Purchase Friedman Aviad Non-Executive Director
500 +5.2%
4.82
US$2,410 		500 +5.2% 4.82 US$2,410
2018-07-12 2018-07-11 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
122 +0.0%
5.92
US$722 		122 +0.0% 5.92 US$722
2018-07-12 2018-07-10 S Sale KIDRON NADAV

President and CEO

Executive Director Large shareholder
61 -0.0%
5.98
US$365 		61 -0.0% 5.98 US$365
2017-08-03 2017-08-02 S Sale Kidron Miriam

Chief Scientific Officer

Executive Director
89,636 -54.4%
8.50
US$761,906 		89,636 -54.4% 8.50 US$761,906
2017-08-03 2017-08-02 B Purchase Li Xiaopeng
89,636 +76.8%
8.50
US$761,906 		89,636 +76.8% 8.50 US$761,906
2017-04-19 2017-04-19 B Purchase Li Xiaopeng
52,814 +82.7%
6.33
US$334,313 		52,814 +82.7% 6.33 US$334,313
2017-04-19 2017-04-19 S Sale Kidron Miriam

Chief Scientific Officer

Executive Director
52,814 -37.1%
6.33
US$334,313 		52,814 -37.1% 6.33 US$334,313
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
7.10
US$710 		100 +0.0% 7.10 US$710
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
7.00
US$2,100 		300 +0.0% 7.00 US$2,100
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
6.91
US$2,073 		300 +0.0% 6.91 US$2,073
2016-05-12 2016-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
300 +0.0%
6.90
US$2,070 		300 +0.0% 6.90 US$2,070
2016-03-14 2016-03-10 S Sale JACOB HAROLD Non-Executive Director
8,500 -34.1%
6.45
US$54,842 		8,500 -34.1% 6.45 US$54,842
2015-12-31 2015-12-30 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
24,000 -14.4%
8.61
US$206,707 		24,000 -14.4% 8.61 US$206,707
2015-12-31 2015-12-29 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
15,000 -8.3%
9.08
US$136,178 		15,000 -8.3% 9.08 US$136,178
2015-12-31 2015-12-28 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
11,000 -5.7%
9.27
US$101,915 		11,000 -5.7% 9.27 US$101,915
2015-12-10 2015-12-09 S Sale Berelowitz Michael Non-Executive Director
700 -3.0%
9.44
US$6,608 		700 -3.0% 9.44 US$6,608
2015-12-09 2015-12-08 S Sale Berelowitz Michael Non-Executive Director
761 -3.1%
8.70
US$6,621 		761 -3.1% 8.70 US$6,621
2015-12-09 2015-12-07 S Sale Berelowitz Michael Non-Executive Director
539 -2.2%
8.70
US$4,689 		539 -2.2% 8.70 US$4,689
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
6.64
US$664 		100 +0.0% 6.64 US$664
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
200 +0.0%
6.63
US$1,326 		200 +0.0% 6.63 US$1,326
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
6.62
US$662 		100 +0.0% 6.62 US$662
2015-05-12 2015-05-12 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
200 +0.0%
6.55
US$1,310 		200 +0.0% 6.55 US$1,310
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
100 +0.0%
4.00
US$400 		100 +0.0% 4.00 US$400
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
1,100 +0.1%
3.92
US$4,312 		1,100 +0.1% 3.92 US$4,312
2015-03-20 2015-03-19 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
400 +0.0%
3.95
US$1,580 		400 +0.0% 3.95 US$1,580
2015-03-20 2015-03-18 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
500 +0.1%
3.80
US$1,900 		500 +0.1% 3.80 US$1,900
2015-03-20 2015-03-18 B Purchase KIDRON NADAV

President and CEO

Executive Director Large shareholder
500 +0.1%
3.78
US$1,890 		500 +0.1% 3.78 US$1,890
2014-09-12 2014-09-11 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
8,699 -7.8%
8.44
US$73,401 		8,699 -7.8% 8.44 US$73,401
2014-09-12 2014-09-10 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
23,000 -17.1%
8.40
US$193,260 		23,000 -17.1% 8.40 US$193,260
2014-09-08 2014-09-04 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
8,301 -5.8%
9.41
US$78,112 		8,301 -5.8% 9.41 US$78,112
2014-06-10 2014-06-06 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
2,252 +0.2%
4.44
US$9,999 		2,252 +0.2% 4.44 US$9,999
2014-04-18 2014-04-14 B Purchase JACOB HAROLD Non-Executive Director
700 New position
14.41
US$10,087 		700 New position 14.41 US$10,087
2014-04-03 2014-04-01 S Sale Kidron Miriam

Chief Technology Officer

Executive Director
137,300 -100.0%
12.03
US$1,651,582 		137,300 -100.0% 12.03 US$1,651,582
2014-04-02 2014-03-31 S Sale Berelowitz Michael Non-Executive Director
9,434 -100.0%
10.50
US$99,057 		9,434 -100.0% 10.50 US$99,057
2014-03-25 2014-03-25 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
47,300 +3.4%
10.90
US$515,551 		47,300 +3.4% 10.90 US$515,551
2014-03-25 2014-03-24 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
27,700 +2.0%
10.15
US$281,257 		27,700 +2.0% 10.15 US$281,257
2014-02-06 2014-02-06 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
26,800 +2.0%
14.96
US$400,941 		26,800 +2.0% 14.96 US$400,941
2014-02-06 2014-02-05 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
24,492 +1.8%
16.32
US$399,798 		24,492 +1.8% 16.32 US$399,798
2014-01-29 2013-12-30 S Sale JACOB HAROLD Non-Executive Director
834 -100.0%
15.00
US$12,510 		834 -100.0% 15.00 US$12,510
2013-07-12 2013-07-10 B Purchase REGALS CAPITAL MANAGEMENT LP Large shareholder
6,630 +0.5%
7.40
US$49,034 		6,630 +0.5% 7.40 US$49,034
2011-10-06 2011-10-04 B Purchase Sank Leonard Non-Executive Director
937,500 New position
0.32
US$300,000 		937,500 New position 0.32 US$300,000
2011-09-28 2011-09-27 S Sale Bronfeld Zeev Large shareholder
350,000 -5.7%
0.28
US$98,000 		350,000 -5.7% 0.28 US$98,000
2011-04-04 2011-03-31 B Purchase Bronfeld Zeev Large shareholder
781,250 +12.1%
0.32
US$250,000 		781,250 +12.1% 0.32 US$250,000
2008-01-17 2008-01-16 B Purchase Sank Leonard Non-Executive Director
5,000 +0.1%
0.25
US$1,250 		5,000 +0.1% 0.25 US$1,250
2008-01-17 2008-01-15 B Purchase Sank Leonard Non-Executive Director
15,650 +0.4%
0.25
US$3,912 		15,650 +0.4% 0.25 US$3,912
2008-01-09 2008-01-07 B Purchase Sank Leonard Non-Executive Director
22,840 +0.6%
0.30
US$6,852 		22,840 +0.6% 0.30 US$6,852
2008-01-07 2008-01-03 B Purchase Sank Leonard Non-Executive Director
48,000 +1.4%
0.30
US$14,400 		48,000 +1.4% 0.30 US$14,400

See older Oramed Pharmaceuticals Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Oramed Pharmaceuticals Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Oramed Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America